Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report

The risk of stroke is heterogeneous across different groups of patients with atrial fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide recommendations for antithrombotic treatment based on net clinical benefit for patients with AF at varying levels of strok...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Chest Ročník 154; číslo 5; s. 1121
Hlavní autoři:	Lip, Gregory Y H, Banerjee, Amitava, Boriani, Giuseppe, Chiang, Chern En, Fargo, Ramiz, Freedman, Ben, Lane, Deirdre A, Ruff, Christian T, Turakhia, Mintu, Werring, David, Patel, Sheena, Moores, Lisa
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.11.2018
Témata:	Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - classification Atrial Fibrillation - complications Atrial Fibrillation - therapy Catheter Ablation - methods Defibrillators, Implantable Electric Countershock - instrumentation Electric Countershock - methods Hemorrhage - chemically induced Hemorrhage - prevention & control Humans Medication Therapy Management - standards Patient Education as Topic - methods Risk Assessment - methods Risk Factors Stroke - etiology Stroke - prevention & control guidelines atrial fibrillation antithrombotic therapy evidence-based medicine
ISSN:	1931-3543, 1931-3543
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!